Ethicann Pharmaceuticals Inc. — Form D/A

Ethicann Pharmaceuticals Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2019-02-07. The offering totals $377K, of which $19K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Brandon PriceDirectorPlantation, FL
Brandon PriceExecutive OfficerPlantation, FL
Brandon PricePromoterPlantation, FL
NEIL MARUOKADirectorBETHESDA, MD
DWAYNE LASHYNDirectorBETHESDA, MD
BRUCE MACKLERDirectorBETHESDA, MD
BRUCE MACKLERExecutive OfficerBETHESDA, MD
BRUCE MACKLERPromoterBETHESDA, MD
ULRICH ELBENExecutive OfficerONTARIO, A6
ROBERT AURITTDirectorONTARIO, A6
ROBERT AURITTExecutive OfficerONTARIO, A6
ROBERT AURITTPromoterONTARIO, A6
Bruce F MacklerDirectorOntario, A6
Bruce F MacklerExecutive OfficerOntario, A6
Bruce F MacklerPromoterOntario, A6
Brandon F PriceDirectorOntario, A6
Brandon F PriceExecutive OfficerOntario, A6
Brandon F PricePromoterOntario, A6
Robert D AurittDirectorOntario, A6
Robert D AurittExecutive OfficerOntario, A6
Robert D AurittPromoterOntario, A6
Dwayne L LashynDirectorOntario, A6
Neil D MaruokaDirectorOntario, A6
Ulrich D ElbenDirectorOntario, A6
Ulrich D ElbenExecutive OfficerOntario, A6

Other filings by this issuer (8)

FiledFormOfferingSold
2022-05-03D$25K
2020-10-08D/A$1.5M
2020-09-04D/A$1.0M
2020-09-03D$1.0M
2019-07-26D/A$1.5M
2019-07-12D$1.5M
2019-02-07D/A$377K$19K
2019-02-07D$377K$19K

More